These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 7965656)
1. Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high-density lipoproteins: role of lipid transfer protein. Wasan KM; Morton RE; Rosenblum MG; Lopez-Berestein G J Pharm Sci; 1994 Jul; 83(7):1006-10. PubMed ID: 7965656 [TBL] [Abstract][Full Text] [Related]
2. Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B. Wasan KM; Rosenblum MG; Cheung L; Lopez-Berestein G Antimicrob Agents Chemother; 1994 Feb; 38(2):223-7. PubMed ID: 8192447 [TBL] [Abstract][Full Text] [Related]
3. The interaction of liposomal amphotericin B and serum lipoproteins within the biological milieu. Wasan KM; Lopez-Berestein G J Drug Target; 1994; 2(5):373-80. PubMed ID: 7704481 [TBL] [Abstract][Full Text] [Related]
4. Modification of amphotericin B's therapeutic index by increasing its association with serum high-density lipoproteins. Wasan KM; Lopez-Berestein G Ann N Y Acad Sci; 1994 Aug; 730():93-106. PubMed ID: 8080218 [TBL] [Abstract][Full Text] [Related]
5. Unidirectional inhibition of lipid transfer protein I-mediated transfer of cholesteryl esters between high-density and low-density lipoproteins by amphotericin B lipid complex. Sivak O; Lau B; Patankar N; Wasan KM Pharm Res; 2004 Dec; 21(12):2336-9. PubMed ID: 15648266 [TBL] [Abstract][Full Text] [Related]
6. Preferential distribution of amphotericin B lipid complex into human HDL3 is a consequence of high density lipoprotein coat lipid content. Kennedy AL; Wasan KM J Pharm Sci; 1999 Nov; 88(11):1149-55. PubMed ID: 10564063 [TBL] [Abstract][Full Text] [Related]
7. Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins. Wasan KM; Brazeau GA; Keyhani A; Hayman AC; Lopez-Berestein G Antimicrob Agents Chemother; 1993 Feb; 37(2):246-50. PubMed ID: 8452354 [TBL] [Abstract][Full Text] [Related]
8. Cyclosporine A transfer between high- and low-density lipoproteins: independent from lipid transfer protein I-facilitated transfer of lipoprotein-coated phospholipids because of high affinity of cyclosporine a for the protein component of lipoproteins. Kwong M; Sivak O; Kwong EH; Wasan KM J Pharm Sci; 2001 Sep; 90(9):1308-17. PubMed ID: 11745783 [TBL] [Abstract][Full Text] [Related]
9. Role of phospholipid transfer protein on the plasma distribution of amphotericin B following the incubation of different amphotericin B formulations. Patankar N; Wasan KM Pharm Res; 2006 May; 23(5):1020-4. PubMed ID: 16715392 [TBL] [Abstract][Full Text] [Related]
10. Diversity of lipid-based polyene formulations and their behavior in biological systems. Wasan KM; Lopez-Berestein G Eur J Clin Microbiol Infect Dis; 1997 Jan; 16(1):81-92. PubMed ID: 9063678 [TBL] [Abstract][Full Text] [Related]
11. Lipid transfer protein I facilitated transfer of cyclosporine from low- to high-density lipoproteins is only partially dependent on its cholesteryl ester transfer activity. Wasan KM; Ramaswamy M; Wong W; Pritchard PH J Pharmacol Exp Ther; 1998 Feb; 284(2):599-605. PubMed ID: 9454803 [TBL] [Abstract][Full Text] [Related]
12. Oxidation of LDL enhances the cholesteryl ester transfer protein (CETP)-mediated cholesteryl ester transfer rate to HDL, bringing on a diminished net transfer of cholesteryl ester from HDL to oxidized LDL. Castilho LN; Oliveira HC; Cazita PM; de Oliveira AC; Sesso A; Quintão EC Clin Chim Acta; 2001 Feb; 304(1-2):99-106. PubMed ID: 11165204 [TBL] [Abstract][Full Text] [Related]
13. Amphotericin B toxicity as related to the formation of oxidatively modified low-density lipoproteins. Barwicz J; Dumont I; Ouellet C; Gruda I Biospectroscopy; 1998; 4(2):135-44. PubMed ID: 9557908 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, distribution in serum lipoproteins and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit model: single-dose studies. Wasan KM; Kennedy AL; Cassidy SM; Ramaswamy M; Holtorf L; Chou JW; Pritchard PH Antimicrob Agents Chemother; 1998 Dec; 42(12):3146-52. PubMed ID: 9835506 [TBL] [Abstract][Full Text] [Related]
15. Low and high density lipoprotein metabolism in primary cultures of hepatic cells from normal and apolipoprotein E knockout mice. Auger A; Truong TQ; Rhainds D; Lapointe J; Letarte F; Brissette L Eur J Biochem; 2001 Apr; 268(8):2322-30. PubMed ID: 11298750 [TBL] [Abstract][Full Text] [Related]
16. Changes in lipid and apolipoprotein composition of pig lipoproteins facilitated by rabbit lipid transfer protein. Abbey M; Calvert GD; Barter PJ Biochim Biophys Acta; 1984 May; 793(3):471-80. PubMed ID: 6712982 [TBL] [Abstract][Full Text] [Related]
17. Plasma cholesteryl ester transfer activity is modulated by the phase transition of the lipoprotein core. Morton RE; Parks JS J Lipid Res; 1996 Sep; 37(9):1915-23. PubMed ID: 8895057 [TBL] [Abstract][Full Text] [Related]
18. Cholesteryl ester transfer protein promotes the association of HDL apolipoproteins A-I and A-II with LDL: potentiation by oleic acid. Lagrost L; Barter PJ Biochim Biophys Acta; 1992 Aug; 1127(3):255-62. PubMed ID: 1511003 [TBL] [Abstract][Full Text] [Related]
19. Effects of various non-esterified fatty acids on the transfer of cholesteryl esters from HDL to LDL induced by the cholesteryl ester transfer protein. Lagrost L; Barter PJ Biochim Biophys Acta; 1991 Sep; 1085(2):209-16. PubMed ID: 1892890 [TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein C-I reduces cholesteryl esters selective uptake from LDL and HDL by binding to HepG2 cells and lipoproteins. Krasteva V; Brodeur MR; Tremblay FL; Falstrault L; Brissette L Biochim Biophys Acta; 2010 Jan; 1801(1):42-8. PubMed ID: 19761869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]